Morristown-Beard (10-5) broke a scoreless tie with two runs in the second inning before putting the game away with a four-run outburst in the seventh. Alex Hriczov led the offense for Morristown ...

Michael Nagle / Bloomberg via Getty Images Shares of Eli Lilly (LLY) fell sharply Thursday morning after the pharmaceutical giant's lowered profit projections outweighed first-quarter results that ...

Here’s an idea for the next episode of “The Eli Manning Show.” The former quarterback visits various investors and tries to pool enough money to buy a minority ownership stake in the Giants.

Eli Manning wants a stake in the Giants. Manning is putting together an investment group to bid for a piece of the Giants, according to Bloomberg. The Giants confirmed in February that they are ...

Philadelphia Eagles cornerback Eli Ricks was among the players who visited the White House and celebrated the team’s Super Bowl victory over the Kansas City Chiefs with President Donald Trump.

Pharmaceutical company Eli Lilly announced promising clinical trial results this week for a daily pill to treat obesity and diabetes. Besides the good news of minimal side effects and impressive ...

In a video posted to the Giants' social media account, Eli Manning sent a congratulatory video to Dart after the latter met with media. Manning wished Dart well, and said he hopes to root for him ...

Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its diabetes treatment Mounjaro, escalating its battle against unauthorized ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced success Thursday of its Phase 3 clinical trial for a once-daily GLP-1 pill — an oral form of the blockbuster medication used for ...

Eli Lilly stock surged as much as 17% after positive phase-three trial data came out for orforglipron. It found orforglipron, a GLP-1 weight-loss pill, led to significant weight and A1C reductions ...

At a hair under $50, this beard trimmer packs 40 length options at a fraction of the price of similar models. It also holds a much longer charge (up to 45 days!) than those more expensive options ...

The move gives Novo Nordisk and Eli Lilly a bit more time of having the only patent-protected GLP-1 drugs on the market. Viking Therapeutics moves toward the head of the pack to become No. 3 ...